Does Teladoc’s Stock Drop Matter? Jamey Edwards on Achieving Health Moonshots in the Face of Rocky Public Markets - podcast episode cover

Does Teladoc’s Stock Drop Matter? Jamey Edwards on Achieving Health Moonshots in the Face of Rocky Public Markets

May 03, 202229 min
--:--
--:--
Listen in podcast apps:
Metacast
Spotify
Youtube
RSS

Episode description

This week’s episode of StartUp Health NOW is a conversation with Jamey Edwards, Chief Operating Officer at StartUp Health. Jamey has been working in the telemedicine space for more than a decade, and his last company, Cloudbreak, went public via SPAC last year. So when we saw the headlines that Teladoc's stock dropped 40% – alongside other dips in the telemedicine public market – we called him up for a dose of perspective. In this conversation with host Logan Plaster, Edwards breaks down the news from Wall Street and gives startups some health moonshot wisdom. Bottom line: stay focused on the mission because improving global health is a marathon, not a sprint. Entrepreneurs: How to get investment from StartUp Health startuphealth.com Investors: How to invest in StartUp Health Moonshots healthmoonshots.com Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
Does Teladoc’s Stock Drop Matter? Jamey Edwards on Achieving Health Moonshots in the Face of Rocky Public Markets | StartUp Health NOW Podcast - Listen or read transcript on Metacast